News
Stocks closed lower Tuesday as investors took a breather from a rally that had pushed major indexes to a series of record ...
As Europe’s healthcare systems grapple with aging populations, rising chronic disease, and overburdened clinicians, digital ...
An accompanying episode of the Annals of Family Medicine Podcast, featuring study authors Ann Sinéad Doherty, PhD, and Emma ...
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
Emerging technology is becoming increasingly crucial to the efficiency and success of health systems. Forty-nine healthcare leaders spoke with Becker’s about the emerging technology that has surprised ...
6d
Zacks Investment Research on MSNAmgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?
Amgen AMGN and Novo Nordisk NVO are among the largest companies in the pharmaceutical space. Amgen boasts one of the largest ...
4d
Zacks Investment Research on MSNHCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View
HCA Healthcare, Inc. HCA reported second-quarter 2025 adjusted earnings per share (EPS) of $6.84, which surpassed the Zacks ...
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...
5d
Medindia on MSNNew Drug Combo Improves Kidney and Blood Sugar Health in Teens With Type 1 Diabetes
A new clinical trial shows that combining dapagliflozin with insulin improves kidney health and blood sugar control, and ...
10h
Barchart on MSNHere’s What Happened the Last Time Novo Nordisk Stock Was This Oversold
Novo Nordisk (NVO) is on pace to gap lower at the opening bell today, with shares of the pharma giant plunging up to 30% in ...
Maziar Mike Doustdar takes over at Novo Nordisk as the company reports weaker earnings than expected on generic challenges to ...
Bagsværd, Denmark, 29 July 2025 - Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds La ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results